Comment on “Cerebroplacental Ratio-based Management Versus Care as Usual in Non–Small-for-Gestational-Age Fetuses At Term With Maternal Perceived Reduced Fetal Movements (CEPRA): A Multicentre, Cluster-randomized Controlled Trial”

View at publisher Summarise with VIRAT
Authors: Aaron Brandon Caughey
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Up to 15% of pregnant people perceive reduced movements of their fetuses. While this is a subjective perception, reduced fetal movements can be an early warning sign of placental dysfunction. Reduced fetal movements increase the risk of stillbirth and other adverse outcomes, including asphyxia and adverse neurodevelopmental outcomes. Currently, there is a wide variation in how providers respond to reports of reduced fetal movement. Doppler ultrasound and serum biomarkers that assess placental function may help identify at-risk fetuses. The cerebroplacental ratio is a measure that looks at how blood is shared between the baby’s brain and placenta. A reduced cerebroplacental ratio may indicate placental dysfunction, so that a redistribution of fetal circulation is necessary as a compensatory response. While a low cerebroplacental ratio has been associated with adverse outcomes in small-for-gestational-age (SGA) fetuses, non-SGA fetuses are an understudied group. The aim of this study was to evaluate whether the cerebroplacental ratio improves perinatal outcomes in uncomplicated, at-term, non-SGA pregnancies with reduced fetal movements. This was a cluster-randomized controlled trial conducted at 22 Dutch hospitals and 1 Australian hospital between July 1, 2020 and September 3, 2024. Included were uncomplicated, at-term, singleton pregnancies with perceived reduced fetal movements, with an estimated fetal weight ≥10th percentile and no reasons for delivery within 4 days. Excluded were people who were younger than 18 years of age, could not give informed consent, or had an abnormal ultrasound indicating fetal compromise, major congenital malformation, or chromosomal abnormality. Clusters of hospitals were randomly assigned 1:1 to either usual care (concealed group) or cerebroplacental ratio-based management (revealed group). The revealed group knew the cerebroplacental ratio and used it to manage a pregnancy, with either expedited birth when the ratio was

Fields of Study & Subjects

Pregnancy and preeclampsia studies Maternal and Perinatal Health Interventions Neonatal and fetal brain pathology

Publication details

Journal / source
Obstetrical & Gynecological Survey
Volume
81
Issue
3
Pages
105–107
Publication date
1 March 2026
Language
EN